Chloe M. Orkin

Chloe M. Orkin

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 205 publications

Phase 3 Trial of Weekly Oral Islatravir-Lenacapavir for HIV-1 Treatment.

Phase 3 Trial of Weekly Oral Islatravir-Lenacapavir for HIV-1 Treatment.

Journal: The New England journal of medicine

Published: July 29, 2026

Time to HIV rebound after antiretroviral therapy interruption: a double-blind randomised placebo-controlled trial of long-acting broadly neutralising antibodies; The RIO Trial.

Time to HIV rebound after antiretroviral therapy interruption: a double-blind randomised placebo-controlled trial of long-acting broadly neutralising antibodies; The RIO Trial.

Journal: medRxiv : the preprint server for health sciences

Published: February 12, 2026

T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy.

T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy.

Journal: medRxiv : the preprint server for health sciences

Published: February 12, 2026

Clinical Characteristics, Healthcare Utilization, and Treatment Patterns Among People Living with HIV by Antiretroviral Therapy Use in the USA, 2021-2024.

Clinical Characteristics, Healthcare Utilization, and Treatment Patterns Among People Living with HIV by Antiretroviral Therapy Use in the USA, 2021-2024.

Journal: Infectious diseases and therapy

Published: February 05, 2026

'Outbreak distress': Characterising moral distress among international healthcare workers responding to mpox.

'Outbreak distress': Characterising moral distress among international healthcare workers responding to mpox.

Journal: Global public health

Published: February 02, 2026

Switch to single-tablet bictegravir-lenacapavir from a complex HIV regimen (ARTISTRY-1): a randomised, open-label, phase 3 clinical trial.

Switch to single-tablet bictegravir-lenacapavir from a complex HIV regimen (ARTISTRY-1): a randomised, open-label, phase 3 clinical trial.

Journal: Lancet (London, England)

Published: January 22, 2026

Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial.

Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial.

Journal: The lancet. HIV

Published: December 09, 2025

What Are the Causes and Consequences of Virological Failure on Long-acting Cabotegravir/Rilpivirine?

What Are the Causes and Consequences of Virological Failure on Long-acting Cabotegravir/Rilpivirine?

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: November 28, 2025

Enhanced HIV-1 Control After Antibody Therapy is Associated with Autologous Antibodies and Reservoir Clearance in the RIO trial.

Enhanced HIV-1 Control After Antibody Therapy is Associated with Autologous Antibodies and Reservoir Clearance in the RIO trial.

Journal: medRxiv : the preprint server for health sciences

Published: November 24, 2025

Analysis of Viral Blips Through Week 192 of the DRIVE-FORWARD and DRIVE-AHEAD Phase 3 Studies of Doravirine-Based Regimens in Adults Living With Previously Untreated HIV-1.

Analysis of Viral Blips Through Week 192 of the DRIVE-FORWARD and DRIVE-AHEAD Phase 3 Studies of Doravirine-Based Regimens in Adults Living With Previously Untreated HIV-1.

Journal: Open forum infectious diseases

Published: November 13, 2025

Doravirine Resistance Patterns Identified through Week 192 in the DRIVE-FORWARD and DRIVE-AHEAD Phase 3 Clinical Trials.

Doravirine Resistance Patterns Identified through Week 192 in the DRIVE-FORWARD and DRIVE-AHEAD Phase 3 Clinical Trials.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: October 23, 2025

Mpox: Exploring Epidemiology, Disease Outcomes, and Preventative Vaccination Among People with HIV During the Ongoing Outbreaks.

Mpox: Exploring Epidemiology, Disease Outcomes, and Preventative Vaccination Among People with HIV During the Ongoing Outbreaks.

Journal: Viruses

Published: August 19, 2025

Showing 1-12 of 205

Last Updated: 09/26/2026